HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hye Jin Kang Selected Research

Stem Cell Transplantation

1/2022Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL)
11/2020Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis.
10/2020Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma.
1/2018Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150).
9/2016The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.
1/2016Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B-cell lymphoma patients.
7/2008Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP.
2/2005High-dose chemotherapy of cyclophosphamide, thiotepa, and carboplatin (CTCb) followed by autologous stem-cell transplantation for metastatic breast cancer patients: a 6-year follow-up result.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hye Jin Kang Research Topics

Disease

17Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2022 - 07/2008
17Neoplasms (Cancer)
09/2022 - 12/2008
15Lymphoma (Lymphomas)
01/2022 - 09/2007
10Multiple Myeloma
01/2022 - 09/2010
8Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 06/2009
7Stomach Neoplasms (Stomach Cancer)
01/2017 - 04/2008
7Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 01/2009
6Infections
10/2022 - 02/2007
4Neutropenia
01/2014 - 04/2010
4Disease Progression
11/2012 - 07/2008
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
04/2012 - 01/2006
3Febrile Neutropenia
10/2022 - 07/2010
3Neoplasm Metastasis (Metastasis)
11/2014 - 09/2008
3Hematologic Neoplasms (Hematological Malignancy)
01/2014 - 12/2008
3Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
11/2012 - 04/2010
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2010 - 04/2008
2Hepatocellular Carcinoma (Hepatoma)
09/2022 - 09/2015
2Thrombosis (Thrombus)
09/2022 - 09/2015
2Breast Neoplasms (Breast Cancer)
12/2021 - 02/2005
2Hodgkin Disease (Hodgkin's Disease)
02/2020 - 11/2019
2Body Weight (Weight, Body)
02/2018 - 01/2014
2Myocardial Infarction
07/2017 - 11/2015
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2015 - 07/2012
2Fever (Fevers)
01/2014 - 12/2013
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2013 - 11/2012
1Substance-Related Disorders (Drug Abuse)
10/2022
1Spinal Cord Injuries (Spinal Cord Injury)
07/2021
1Urinary Tract Infections (Urinary Tract Infection)
07/2021
1Overactive Urinary Bladder (Overactive Bladder)
07/2021
1Nervous System Diseases (Neurological Disorders)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Pain (Aches)
01/2021
1Schizophrenia (Dementia Praecox)
01/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Opioid-Related Disorders (Opiate Addiction)
01/2021
1Burkitt Lymphoma (Burkitt's Lymphoma)
05/2020

Drug/Important Bio-Agent (IBA)

16Rituximab (Mabthera)FDA Link
10/2022 - 07/2008
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022 - 02/2005
10Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2020 - 06/2009
7Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 09/2010
7Vincristine (Oncovin)FDA LinkGeneric
10/2022 - 02/2012
7Bortezomib (Velcade)FDA Link
01/2020 - 09/2010
7Cisplatin (Platino)FDA LinkGeneric
11/2012 - 12/2002
6Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 07/2008
5Melphalan (Alkeran)FDA LinkGeneric
01/2022 - 01/2017
5Etoposide (VP 16)FDA LinkGeneric
01/2022 - 12/2002
5Irinotecan (Camptosar)FDA LinkGeneric
01/2017 - 07/2008
5Imatinib Mesylate (Gleevec)FDA Link
04/2012 - 01/2006
4Prednisolone (Predate)FDA LinkGeneric
10/2022 - 03/2015
4Busulfan (Busulfex)FDA Link
01/2022 - 01/2018
4R-CHOP protocolIBA
01/2020 - 04/2015
4Prednisone (Sone)FDA LinkGeneric
09/2017 - 11/2012
4Fluorouracil (Carac)FDA LinkGeneric
01/2017 - 07/2010
4Cetuximab (Erbitux)FDA Link
02/2015 - 04/2011
4Capecitabine (Xeloda)FDA Link
11/2014 - 07/2010
3Cytarabine (Cytosar-U)FDA LinkGeneric
10/2020 - 06/2009
3Leucovorin (Folinic Acid)FDA Link
01/2017 - 07/2013
3Thalidomide (Thalomid)FDA Link
01/2017 - 09/2010
3Docetaxel (Taxotere)FDA Link
11/2012 - 12/2008
3PlatinumIBA
02/2012 - 12/2002
2Lenalidomide (CC 5013)FDA Link
01/2022 - 01/2020
2ErbB Receptors (EGF Receptor)IBA
12/2021 - 02/2007
2MethylprednisoloneFDA LinkGeneric
02/2020 - 06/2009
2131I-rituximabIBA
12/2019 - 04/2013
2CreatinineIBA
04/2018 - 12/2016
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2017 - 10/2008
2SteroidsIBA
01/2017 - 03/2015
2Methotrexate (Mexate)FDA LinkGeneric
12/2016 - 03/2012
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2016 - 09/2016
2Simvastatin (Zocor)FDA LinkGeneric
02/2015 - 06/2014
2Itraconazole (Sporanox)FDA LinkGeneric
01/2014 - 01/2014
2DNA (Deoxyribonucleic Acid)IBA
04/2012 - 02/2007
2GemcitabineFDA Link
02/2012 - 04/2010
2Gefitinib (Iressa)FDA Link
12/2010 - 04/2008
1pegfilgrastim (Neulasta)FDA Link
10/2022
1KetamineFDA LinkGeneric
10/2022
1Proteins (Proteins, Gene)FDA Link
10/2022
16-hydroxynorketamineIBA
10/2022
1Methadone (Dolophine)FDA LinkGeneric
01/2021
1Opioid Analgesics (Opioids)IBA
01/2021
1Oxycodone (Oxycontin)FDA LinkGeneric
01/2021
1Analgesics (Analgesic Drugs)IBA
01/2021
1metabotropic glutamate receptor 2IBA
01/2021
1Morphine (MS Contin)FDA LinkGeneric
01/2021
1Carmustine (FIVB)FDA Link
10/2020
1Atorvastatin (Lipitor)FDA Link
05/2020
1Brentuximab VedotinIBA
04/2020
1pomalidomideIBA
01/2020

Therapy/Procedure

22Drug Therapy (Chemotherapy)
01/2022 - 12/2002
18Therapeutics
01/2022 - 12/2008
12Combination Drug Therapy (Combination Chemotherapy)
02/2020 - 12/2002
8Stem Cell Transplantation
01/2022 - 02/2005
7Radiotherapy
09/2022 - 12/2002
6Radioimmunotherapy
05/2020 - 01/2013
3Induction Chemotherapy
01/2016 - 02/2012
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
12/2017 - 03/2016
2Aftercare (After-Treatment)
12/2013 - 10/2006
2Adjuvant Chemotherapy
11/2012 - 08/2010
1Indwelling Catheters (Indwelling Catheter)
07/2021
1Nursing Care
07/2021